GILEAD SCIENCES (GIS HM) stock market data APIs
€119.9836
0.15(0.1%)
as of April 1, 2026
Try our APIs with
free plan!
GILEAD SCIENCES Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for GIS.HM.
Prev. Close
119.9836
Open
120.1385
High
120.4353
Low
119.8727
52 wk Range
80.4528-130.2788
Market Cap
78 028 M
Dividends (Yield)
0.0266
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GILEAD SCIENCES data using free add-ons & libraries
Get GILEAD SCIENCES Fundamental Data
GILEAD SCIENCES Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GILEAD SCIENCES News
New
Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Gilead Sciences (GILD) closed the most recent trading day at $139.37, moving +2.22% from the previous trading session. This move lagged the S&P 500's daily gain of 2.91%. Meanwhile, the Dow gained 2.4...
Gilead Sciences Shows Solid Early Yeztugo Persistence but Limited Market Expansion, RBC Says
Gilead Sciences (GILD) HIV prevention drug Yeztugo is seeing "decent" patient persistence based on e PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Gilead Expands Autoimmune Ambitions With Ouro Deal And Galapagos Collaboration
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Gilead Sciences (NasdaqGS:GILD) has entered a definitive ...
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
Galapagos NV New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos Following this transaction, the Company will continue to have a majority of its ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
